Tenax Therapeutics, Inc. (TENX)
NASDAQ·Healthcare·Biotechnology
$14.59
-3.44%
Mkt Cap $50.28M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 10, 2026 | — | — | — | -$1.26 | -$0.38 | +69.84% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$1.33 | -$0.40 | +69.92% | — | — |
| Q3 2025 Aug 13, 2025 | — | — | — | -$0.50 | -$0.27 | +46.00% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | -$0.48 | -$0.28 | +41.67% | — | — |
| Q1 2025 Mar 25, 2025 | — | — | — | -$0.52 | -$0.18 | +65.38% | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | -$1.38 | -$0.19 | +86.23% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$1.99 | -$1.83 | +8.04% | — | — |
| Q2 2024 May 14, 2024 | — | — | — | -$2.40 | -$3.12 | -30.00% | — | — |
| Q1 2024 Mar 28, 2024 | — | $5.79K | — | -$8.14 | -$12.98 | -59.46% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$7.20 | -$6.40 | +11.11% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | -$0.10 | -$4.00 | -3900.00% | — | — |
| Q2 2023 May 15, 2023 | — | — | — | -$0.37 | -$12.00 | -3143.24% | — | — |
| Q1 2023 Mar 30, 2023 | — | — | — | -$2.28 | -$1.73 | +24.12% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$176.00 | -$176.00 | +0.00% | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | -$144.00 | -$176.00 | -22.22% | — | — |
| Q2 2022 May 16, 2022 | — | — | — | -$144.00 | -$176.00 | -22.22% | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | -$3.20 | -$0.80 | +75.00% | — | — |
| Q4 2021 Nov 16, 2021 | — | — | — | -$208.00 | -$240.00 | -15.38% | — | — |
| Q3 2021 Aug 16, 2021 | — | — | — | -$0.13 | -$160.00 | -122976.92% | — | — |
| Q2 2021 May 17, 2021 | — | — | — | -$336.00 | -$2624.00 | -680.95% | — | — |